{"pmid":32320138,"title":"Management of ST-segment-elevation myocardial infarction during the coronavirus disease 2019 (COVID-19) outbreak: Iranian\"247\" National Committee's position paper on primary percutaneous coronary intervention.","text":["Management of ST-segment-elevation myocardial infarction during the coronavirus disease 2019 (COVID-19) outbreak: Iranian\"247\" National Committee's position paper on primary percutaneous coronary intervention.","World Health Organization has designated coronavirus disease 2019 (COVID-19) as a pandemic. During the past several weeks, a considerable burden has been imposed on the Iranian's healthcare system. The present document reviewed the latest evidence and expert opinion regarding the management of ST-segment-elevation myocardial infarction during the outbreak of COVID-19 and outlines a practical algorithm for it.","Catheter Cardiovasc Interv","Sadeghipour, Parham","Talasaz, Azita H","Eslami, Vahid","Gerayeli, Babak","Vojdanparast, Mohammad","Sedaghat, Mojtaba","Moosavi, Abouzar Fakhr","Alipour-Parsa, Saeed","Aminian, Bahram","Firouzi, Ata","Ghafari, Samad","Ghasemi, Massoud","Saleh, Davood Kazemi","Khosravi, Alireza","Kojuri, Javad","Noohi, Feridoun","Pourhosseini, Hamid","Salarifar, Mojtaba","Salehi, Mohamad Reza","Sezavar, Hashem","Shabestari, Mahmoud","Soleimani, Abbas","Tabarsi, Payam","Parsa, Amir Farhang Zand","Abdi, Seifollah","32320138"],"abstract":["World Health Organization has designated coronavirus disease 2019 (COVID-19) as a pandemic. During the past several weeks, a considerable burden has been imposed on the Iranian's healthcare system. The present document reviewed the latest evidence and expert opinion regarding the management of ST-segment-elevation myocardial infarction during the outbreak of COVID-19 and outlines a practical algorithm for it."],"journal":"Catheter Cardiovasc Interv","authors":["Sadeghipour, Parham","Talasaz, Azita H","Eslami, Vahid","Gerayeli, Babak","Vojdanparast, Mohammad","Sedaghat, Mojtaba","Moosavi, Abouzar Fakhr","Alipour-Parsa, Saeed","Aminian, Bahram","Firouzi, Ata","Ghafari, Samad","Ghasemi, Massoud","Saleh, Davood Kazemi","Khosravi, Alireza","Kojuri, Javad","Noohi, Feridoun","Pourhosseini, Hamid","Salarifar, Mojtaba","Salehi, Mohamad Reza","Sezavar, Hashem","Shabestari, Mahmoud","Soleimani, Abbas","Tabarsi, Payam","Parsa, Amir Farhang Zand","Abdi, Seifollah"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32320138","week":"202017|Apr 20 - Apr 26","doi":"10.1002/ccd.28889","keywords":["acute myocardial infarction/stemi","percutaneous coronary intervention","thrombolytic therapy"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["Iranian"],"countries":["Iran, Islamic Republic of"],"countries_codes":["IRN|Iran, Islamic Republic of"],"_version_":1664815087737634816,"score":8.518259,"similar":[{"pmid":32311816,"title":"Management of Acute Myocardial Infarction During the COVID-19 Pandemic.","text":["Management of Acute Myocardial Infarction During the COVID-19 Pandemic.","The worldwide pandemic caused by the novel acute respiratory syndrome coronavirus 2 (SARS-CoV2) has resulted in a new and lethal disease termed coronavirus disease 2019 (COVID-19). Although there is an association between cardiovascular disease and COVID-19, the majority of patients who need cardiovascular care for the management of ischemic heart disease may not be infected with COVID-19. The objective of this document is to provide recommendations for a systematic approach for the care of patients with an acute myocardial infarction (AMI) during the COVID-19 pandemic. There is a recognition of two major challenges in providing recommendations for AMI care in the COVID-19 era. Cardiovascular manifestations of COVID-19 are complex with patients presenting with AMI, myocarditis simulating a ST-elevation MI presentation, stress cardiomyopathy, non-ischemic cardiomyopathy, coronary spasm, or nonspecific myocardial injury and the prevalence of COVID-19 disease in the US population remains unknown with risk of asymptomatic spread. This document addresses the care of these patients focusing on 1) the varied clinical presentations; 2) appropriate personal protection equipment (PPE) for health care workers; 3) role of the Emergency Department, Emergency Medical System and the Cardiac Catheterization Laboratory; and 4) Regional STEMI systems of care. During the COVID-19 pandemic, primary PCI remains the standard of care for STEMI patients at PCI capable hospitals when it can be provided in a timely fashion, with an expert team outfitted with PPE in a dedicated CCL room. A fibrinolysis-based strategy may be entertained at non-PCI capable referral hospitals or in specific situations where primary PCI cannot be executed or is not deemed the best option. This article is protected by copyright. All rights reserved.","Catheter Cardiovasc Interv","Mahmud, Ehtisham","Dauerman, Harold L","Welt, Frederick Gp","Messenger, John C","Rao, Sunil V","Grines, Cindy","Mattu, Amal","Kirtane, Ajay J","Jauhar, Rajiv","Meraj, Perwaiz","Rokos, Ivan C","Rumsfeld, John S","Henry, Timothy D","32311816"],"abstract":["The worldwide pandemic caused by the novel acute respiratory syndrome coronavirus 2 (SARS-CoV2) has resulted in a new and lethal disease termed coronavirus disease 2019 (COVID-19). Although there is an association between cardiovascular disease and COVID-19, the majority of patients who need cardiovascular care for the management of ischemic heart disease may not be infected with COVID-19. The objective of this document is to provide recommendations for a systematic approach for the care of patients with an acute myocardial infarction (AMI) during the COVID-19 pandemic. There is a recognition of two major challenges in providing recommendations for AMI care in the COVID-19 era. Cardiovascular manifestations of COVID-19 are complex with patients presenting with AMI, myocarditis simulating a ST-elevation MI presentation, stress cardiomyopathy, non-ischemic cardiomyopathy, coronary spasm, or nonspecific myocardial injury and the prevalence of COVID-19 disease in the US population remains unknown with risk of asymptomatic spread. This document addresses the care of these patients focusing on 1) the varied clinical presentations; 2) appropriate personal protection equipment (PPE) for health care workers; 3) role of the Emergency Department, Emergency Medical System and the Cardiac Catheterization Laboratory; and 4) Regional STEMI systems of care. During the COVID-19 pandemic, primary PCI remains the standard of care for STEMI patients at PCI capable hospitals when it can be provided in a timely fashion, with an expert team outfitted with PPE in a dedicated CCL room. A fibrinolysis-based strategy may be entertained at non-PCI capable referral hospitals or in specific situations where primary PCI cannot be executed or is not deemed the best option. This article is protected by copyright. All rights reserved."],"journal":"Catheter Cardiovasc Interv","authors":["Mahmud, Ehtisham","Dauerman, Harold L","Welt, Frederick Gp","Messenger, John C","Rao, Sunil V","Grines, Cindy","Mattu, Amal","Kirtane, Ajay J","Jauhar, Rajiv","Meraj, Perwaiz","Rokos, Ivan C","Rumsfeld, John S","Henry, Timothy D"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32311816","week":"202017|Apr 20 - Apr 26","doi":"10.1002/ccd.28946","keywords":["covid-19","stemi","acute myocardial infarction","emergency medical system","fibrinolysis","percutaneous coronary intervention"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["US"],"countries":["United States"],"countries_codes":["USA|United States"],"_version_":1664632501467873280,"score":302.16714},{"pmid":32330544,"title":"Management of Acute Myocardial Infarction During the COVID-19 Pandemic.","text":["Management of Acute Myocardial Infarction During the COVID-19 Pandemic.","The worldwide pandemic caused by the novel acute respiratory syndrome coronavirus 2 (SARS-CoV2) has resulted in a new and lethal disease termed coronavirus disease 2019 (COVID-19). Although there is an association between cardiovascular disease and COVID-19, the majority of patients who need cardiovascular care for the management of ischemic heart disease may not be infected with COVID-19. The objective of this document is to provide recommendations for a systematic approach for the care of patients with an acute myocardial infarction (AMI) during the COVID-19 pandemic. There is a recognition of two major challenges in providing recommendations for AMI care in the COVID-19 era. Cardiovascular manifestations of COVID-19 are complex with patients presenting with AMI, myocarditis simulating a ST-elevation MI presentation, stress cardiomyopathy, non-ischemic cardiomyopathy, coronary spasm, or nonspecific myocardial injury and the prevalence of COVID-19 disease in the US population remains unknown with risk of asymptomatic spread. This document addresses the care of these patients focusing on 1) the varied clinical presentations; 2) appropriate personal protection equipment (PPE) for health care workers; 3) role of the Emergency Department, Emergency Medical System and the Cardiac Catheterization Laboratory; and 4) Regional STEMI systems of care. During the COVID-19 pandemic, primary PCI remains the standard of care for STEMI patients at PCI capable hospitals when it can be provided in a timely fashion, with an expert team outfitted with PPE in a dedicated CCL room. A fibrinolysis-based strategy may be entertained at non-PCI capable referral hospitals or in specific situations where primary PCI cannot be executed or is not deemed the best option.","J Am Coll Cardiol","Mahmud, Ehtisham","Dauerman, Harold L","Welt, Frederick Gp","Messenger, John C","Rao, Sunil V","Grines, Cindy","Mattu, Amal","Kirtane, Ajay J","Jauhar, Rajiv","Meraj, Perwaiz","Rokos, Ivan C","Rumsfeld, John S","Henry, Timothy D","32330544"],"abstract":["The worldwide pandemic caused by the novel acute respiratory syndrome coronavirus 2 (SARS-CoV2) has resulted in a new and lethal disease termed coronavirus disease 2019 (COVID-19). Although there is an association between cardiovascular disease and COVID-19, the majority of patients who need cardiovascular care for the management of ischemic heart disease may not be infected with COVID-19. The objective of this document is to provide recommendations for a systematic approach for the care of patients with an acute myocardial infarction (AMI) during the COVID-19 pandemic. There is a recognition of two major challenges in providing recommendations for AMI care in the COVID-19 era. Cardiovascular manifestations of COVID-19 are complex with patients presenting with AMI, myocarditis simulating a ST-elevation MI presentation, stress cardiomyopathy, non-ischemic cardiomyopathy, coronary spasm, or nonspecific myocardial injury and the prevalence of COVID-19 disease in the US population remains unknown with risk of asymptomatic spread. This document addresses the care of these patients focusing on 1) the varied clinical presentations; 2) appropriate personal protection equipment (PPE) for health care workers; 3) role of the Emergency Department, Emergency Medical System and the Cardiac Catheterization Laboratory; and 4) Regional STEMI systems of care. During the COVID-19 pandemic, primary PCI remains the standard of care for STEMI patients at PCI capable hospitals when it can be provided in a timely fashion, with an expert team outfitted with PPE in a dedicated CCL room. A fibrinolysis-based strategy may be entertained at non-PCI capable referral hospitals or in specific situations where primary PCI cannot be executed or is not deemed the best option."],"journal":"J Am Coll Cardiol","authors":["Mahmud, Ehtisham","Dauerman, Harold L","Welt, Frederick Gp","Messenger, John C","Rao, Sunil V","Grines, Cindy","Mattu, Amal","Kirtane, Ajay J","Jauhar, Rajiv","Meraj, Perwaiz","Rokos, Ivan C","Rumsfeld, John S","Henry, Timothy D"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330544","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.jacc.2020.04.039","keywords":["covid-19","stemi","acute myocardial infarction","emergency medical system","fibrinolysis","percutaneous coronary intervention"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["US"],"countries":["United States"],"countries_codes":["USA|United States"],"_version_":1664996914860392450,"score":302.16714},{"pmid":32182131,"pmcid":"PMC7147280","title":"Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China.","text":["Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China.","Circ Cardiovasc Qual Outcomes","Tam, Chor-Cheung Frankie","Cheung, Kent-Shek","Lam, Simon","Wong, Anthony","Yung, Arthur","Sze, Michael","Lam, Yui-Ming","Chan, Carmen","Tsang, Tat-Chi","Tsui, Matthew","Tse, Hung-Fat","Siu, Chung-Wah","32182131"],"journal":"Circ Cardiovasc Qual Outcomes","authors":["Tam, Chor-Cheung Frankie","Cheung, Kent-Shek","Lam, Simon","Wong, Anthony","Yung, Arthur","Sze, Michael","Lam, Yui-Ming","Chan, Carmen","Tsang, Tat-Chi","Tsui, Matthew","Tse, Hung-Fat","Siu, Chung-Wah"],"date":"2020-03-18T11:00:00Z","year":2020,"_id":"32182131","week":"202012|Mar 16 - Mar 22","doi":"10.1161/CIRCOUTCOMES.120.006631","source":"PubMed","topics":["Treatment"],"weight":1,"locations":["China","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640874574774273,"score":155.94012},{"pmid":32315733,"title":"Elevated troponin in patients with Coronavirus Disease 2019 (COVID-19): possible mechanisms.","text":["Elevated troponin in patients with Coronavirus Disease 2019 (COVID-19): possible mechanisms.","Coronavirus disease 2019 (COVID-19) is a pandemic that has affected more than 1.8 million people worldwide, overwhelmed health care systems due to the high proportion of critical presentations, and resulted in over 100,000 deaths. Since the first data analyses in China, elevated cardiac troponin has been noted in a substantial proportion of patients, implicating myocardial injury as a possible pathogenic mechanism contributing to severe illness and mortality. Accordingly, high troponin levels are associated with increased mortality in patients with COVID-19. This brief review explores the available evidence regarding the association between COVID-19 and myocardial injury.","J Card Fail","Tersalvi, Gregorio","Vicenzi, Marco","Calabretta, Davide","Biasco, Luigi","Pedrazzini, Giovanni","Winterton, Dario","32315733"],"abstract":["Coronavirus disease 2019 (COVID-19) is a pandemic that has affected more than 1.8 million people worldwide, overwhelmed health care systems due to the high proportion of critical presentations, and resulted in over 100,000 deaths. Since the first data analyses in China, elevated cardiac troponin has been noted in a substantial proportion of patients, implicating myocardial injury as a possible pathogenic mechanism contributing to severe illness and mortality. Accordingly, high troponin levels are associated with increased mortality in patients with COVID-19. This brief review explores the available evidence regarding the association between COVID-19 and myocardial injury."],"journal":"J Card Fail","authors":["Tersalvi, Gregorio","Vicenzi, Marco","Calabretta, Davide","Biasco, Luigi","Pedrazzini, Giovanni","Winterton, Dario"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32315733","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.cardfail.2020.04.009","keywords":["covid-19","sars","coronavirus","myocardial injury","myocarditis","troponin"],"source":"PubMed","topics":["Mechanism","Treatment"],"weight":1,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664714520037163010,"score":133.52988},{"pmid":32233980,"title":"Protected Code Stroke: Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic.","text":["Protected Code Stroke: Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic.","Background and Purpose- Hyperacute assessment and management of patients with stroke, termed code stroke, is a time-sensitive and high-stakes clinical scenario. In the context of the current Coronavirus Disease 2019 (COVID-19) pandemic caused by the SARS-CoV-2 virus, the ability to deliver timely and efficacious care must be balanced with the risk of infectious exposure to the clinical team. Furthermore, rapid and effective stroke care remains paramount to achieve maximal functional recovery for those needing admission and to triage care appropriately for those who may be presenting with neurological symptoms but have an alternative diagnosis. Methods- Available resources, COVID-19-specific infection prevention and control recommendations, and expert consensus were used to identify clinical screening criteria for patients and provide the required nuanced considerations for the healthcare team, thereby modifying the conventional code stroke processes to achieve a protected designation. Results- A protected code stroke algorithm was developed. Features specific to prenotification and clinical status of the patient were used to define precode screening. These include primary infectious symptoms, clinical, and examination features. A focused framework was then developed with regard to a protected code stroke. We outline the specifics of personal protective equipment use and considerations thereof including aspects of crisis resource management impacting team role designation and human performance factors during a protected code stroke. Conclusions- We introduce the concept of a protected code stroke during a pandemic, as in the case of COVID-19, and provide a framework for key considerations including screening, personal protective equipment, and crisis resource management. These considerations and suggested algorithms can be utilized and adapted for local practice.","Stroke","Khosravani, Houman","Rajendram, Phavalan","Notario, Lowyl","Chapman, Martin G","Menon, Bijoy K","32233980"],"abstract":["Background and Purpose- Hyperacute assessment and management of patients with stroke, termed code stroke, is a time-sensitive and high-stakes clinical scenario. In the context of the current Coronavirus Disease 2019 (COVID-19) pandemic caused by the SARS-CoV-2 virus, the ability to deliver timely and efficacious care must be balanced with the risk of infectious exposure to the clinical team. Furthermore, rapid and effective stroke care remains paramount to achieve maximal functional recovery for those needing admission and to triage care appropriately for those who may be presenting with neurological symptoms but have an alternative diagnosis. Methods- Available resources, COVID-19-specific infection prevention and control recommendations, and expert consensus were used to identify clinical screening criteria for patients and provide the required nuanced considerations for the healthcare team, thereby modifying the conventional code stroke processes to achieve a protected designation. Results- A protected code stroke algorithm was developed. Features specific to prenotification and clinical status of the patient were used to define precode screening. These include primary infectious symptoms, clinical, and examination features. A focused framework was then developed with regard to a protected code stroke. We outline the specifics of personal protective equipment use and considerations thereof including aspects of crisis resource management impacting team role designation and human performance factors during a protected code stroke. Conclusions- We introduce the concept of a protected code stroke during a pandemic, as in the case of COVID-19, and provide a framework for key considerations including screening, personal protective equipment, and crisis resource management. These considerations and suggested algorithms can be utilized and adapted for local practice."],"journal":"Stroke","authors":["Khosravani, Houman","Rajendram, Phavalan","Notario, Lowyl","Chapman, Martin G","Menon, Bijoy K"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32233980","week":"202014|Mar 30 - Apr 05","doi":"10.1161/STROKEAHA.120.029838","keywords":["covid-19","algorithms","consensus","pandemics","stroke"],"source":"PubMed","topics":["Diagnosis","Prevention"],"weight":1,"_version_":1664638354236375041,"score":131.11975}]}